1392515-06-8

Basic information

• Product Name: (1R,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-ol
• Synonyms: (1R,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-ol
• CAS NO: 1392515-06-8
• Molecular Weight: 452.556
• Mol File: 1392515-06-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (1R,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-ol(1392515-06-8)
• EPA Substance Registry System: (1R,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-ol(1392515-06-8)

Safety Data

• Hazardous Substances Data: 1392515-06-8(Hazardous Substances Data)

Upstream product

• 10277-74-4 (S)-1-Aminoindane 
• 1370007-76-3 C₂₀H₂₁N₃O₄S 
• 3587-60-8 Benzyloxymethyl chloride 
• 628733-99-3 ethyl 1-amino-1H-pyrrole-2-carboxylate 
• 159326-71-3 pyrrolo[1,2-f][1,2,4]triazin-4-ol 
• 1269667-51-7 7-bromo-4-chloropyrrolo[2,1-f][1,2,4]triazine 
• 1370007-53-6 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-ol 
• 1370007-54-7 7-bromo-4-(methylthio)pyrrolo[2,1-f][1,2,4]triazine 
• 188399-48-6 (1R,2S)-2-((benzyloxy)methyl)cyclopent-3-en-1-ol 
• 1370007-75-2 (1R,4S)-2-(benzyloxymethyl)-4-(4-methylsulfanylpyrrolo[2,1-f][1,2,4]triazin-7-yl)cyclopent-2-en-1-ol 
• 2199-43-1 ethyl 1H-pyrrole-2-carboxylate 

Downstream Products

• 1370007-78-5 [(1S,4S)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopent-2-en-1-yl] benzoate 
• 1370007-80-9 [(1S,2R,4R)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopentyl] benzoate 
• 1370007-82-1 [(1S,2S,4R)-2-(benzyloxymethyl)-4-[4-[[(1S)-indan-1-yl]amino]pyrrolo[2,1-f][1,2,4]triazin-7-yl]cyclopentyl] benzoate 

Relevant articles and documents

SULFONAMIDE, SULFAMATE, AND SULFAMOTHIOATE DERIVATIVES

The disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof, compositions containing these compounds, and methods of using these compounds in a variety applications, such as treatment of diseases or disorders associated with E1 type activating enzymes, and with Nedd8 activating enzyme (NAE) in particular.